Rizatriptan Benzoate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Rizatriptan Benzoate
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Rizatriptan Benzoate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 21 USDMF, 12 CEP/COS, 4 JDMF, 16 EU WC, 14 NDC API, 21 Listed Suppliers, $ API Reference Price

33 API Suppliers
21 USDMF
12 CEP/COS
4 JDMF
16 EU WC
14 NDC API
21 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

299 FDF Dossiers, 55 FDA Orange Book, 160 Europe, 38 Canada, 6 Australia, 15 South Africa, 25 Listed Dossiers

299 FDF Dossiers
55 FDA Orange Book
160 Europe
38 Canada
6 Australia
15 South Africa
25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE
TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 6 Rochem International Inc, 19 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 4 ACG Worldwide, 3 Actylis, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 6 DFE Pharma, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 31 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 NEWEDGE Overseas, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 6 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

81 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 33 Direct Compression, 28 Taste Masking, 23 Granulation, 23 Chewable & Orodispersible Aids, 22 Thickeners and Stabilizers, 22 Controlled & Modified Release, 17 Lubricants & Glidants, 17 Film Formers & Plasticizers, 14 Co-Processed Excipients, 9 Empty Capsules, 9 Parenteral, 5 Solubilizers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 2 Topical, 1 Soft Gelatin

81 Fillers, Diluents & Binders
47 Coating Systems & Additives
46 Disintegrants & Superdisintegrants
33 Direct Compression
28 Taste Masking
23 Granulation
23 Chewable & Orodispersible Aids
22 Thickeners and Stabilizers
22 Controlled & Modified Release
17 Lubricants & Glidants
17 Film Formers & Plasticizers
14 Co-Processed Excipients
9 Empty Capsules
9 Parenteral
5 Solubilizers
4 Vegetarian Capsules
4 API Stability Enhancers
4 Emulsifying Agents
3 Rheology Modifiers
2 Coloring Agents
2 Topical
1 Soft Gelatin

DIGITAL CONTENT

1 STOCK RECAP #PipelineProspector, 14 NEWS #PharmaBuzz

1 STOCK RECAP #PipelineProspector
14 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 160 Finished Drug Prices

2 US Medicaid Prescriptions
160 Finished Drug Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 4 Health Canada Patents

1 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 Others

2 EDQM
2 USP
2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 8,320 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Merck Canada Inc.

filter Patent Reset all filters

4 All

01 42060139

filter Product Reset all filters

4 All

01 4Rizatriptan Benzoate

filter Dosage Reset all filters

4 All

01 2Tablet

02 2Wafer

filter Exp Date Reset all filters

4 All

01 42012-01-28

Product Main Page

01

Merck Canada Inc.

Rizatriptan Benzoate

BioAsia

Not Confirmed

Merck Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

Rizatriptan Benzoate

Brand Name : MAXALT

Patent Number : 2060139

Filing Date : 1992-01-28

Strength per Unit : 5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Rizatriptan Benzoate

BioAsia

Not Confirmed

Merck Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

Rizatriptan Benzoate

Brand Name : MAXALT

Patent Number : 2060139

Filing Date : 1992-01-28

Strength per Unit : 10mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Merck Canada Inc.

Rizatriptan Benzoate

BioAsia

Not Confirmed

Merck Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

Rizatriptan Benzoate

Brand Name : MAXALT RPD

Patent Number : 2060139

Filing Date : 1992-01-28

Strength per Unit : 5mg

Dosage Form : Wafer

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Merck Canada Inc.

Rizatriptan Benzoate

BioAsia

Not Confirmed

Merck Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

Rizatriptan Benzoate

Brand Name : MAXALT RPD

Patent Number : 2060139

Filing Date : 1992-01-28

Strength per Unit : 10mg

Dosage Form : Wafer

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-01-28

Date Granted : 1998-12-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!